Opioids and Benzodiazepines - 19/04/18
Doi : 10.1016/S0749-0704(18)30042-3
Michael J. Murray, MD, PhD ⁎, Martin L. DeRuyter, MD, Barry A. Harrison, MD
From the Mayo Medical School; and the Department of Anesthesiology and Critical Care Service, Mayo Clinic and Mayo Foundation, Rochester, Minnesota
*Address reprint requests to: Michael J. Murray, MD, PhD Mayo Clinic, 200 First Street SW, Rochester, MN 55905Mayo Clinic200 First Street SWRochesterMN55905
Résumé |
Most patients in the intensive care unit experience pain and anxiety, which are treated most commonly with an opioid or a benzodiazepine. These compounds are effective and have a well-established safety record. With the exception of associated respiratory depression, they have a relatively wide therapeutic window. New approaches and formulations for opioids and benzodiazepines are being used with continued success in the clinical setting.
Le texte complet de cet article est disponible en PDF.© 1995
Elsevier Inc. Tous droits réservés.
Vol 11 - N° 4
P. 849-873 - octobre 1995 Retour au numéro
Article précédent
- Optimal Intravenous Dosing Strategies for Sedatives and Analgesics in the Intensive Care Unit
- Juliana Barr, Andrew Donner
- Barbiturates, Neuroleptics, And Propofol for Sedation
- Niels Lund, Peter J. Papadakos
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?